Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
ACR Open Rheumatology|May 9, 2025
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid ArthritisJürgen Wollenhaupt, Jacques Morel, Claire Daien, et al.
The Journal of Rheumatology|June 3, 2019
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid ArthritisPaul Emery, Bonnie Vlahos, Piotr Szczypa, et al.
Clinical Rheumatology|July 11, 2014
Clinical and immunogenetic characterization in psoriatic arthritis patientsEmilce Edith Schneeberger, Gustavo Citera, Gustavo Rodríguez Gil, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 17, 2024
Cardiovascular Events, Malignancies, and Efficacy Outcomes in Latin American Patients With Rheumatoid Arthritis Receiving Tofacitinib or Tumor Necrosis Factor Inhibitors: A Post Hoc Analysis of the ORAL Surveillance StudyGustavo Citera, Eduardo Mysler, Adriana Maria Kakehasi, et al.
Seminars in Arthritis and Rheumatism|December 8, 2022
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studiesEmilce E Schneeberger, Gustavo Citera, Peter Nash, et al.
Seminars in Arthritis and Rheumatism|September 19, 2019
Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaireElena Myasoedova, Annette De Thurah, Marie-Line Erpelding, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 23, 2010
The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city of Buenos Aires provinceDario Scublinsky, Horacio Venarotti, Gustavo Citera, et al.
Annals of the Rheumatic Diseases|August 3, 2022
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trialAndra-Rodica Balanescu, Gustavo Citera, Virginia Pascual-Ramos, et al.
Reumatologia Clinica|June 19, 2016
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studiesSebastião Cezar Radominski, Mario Humberto Cardiel, Gustavo Citera, et al.
Advances in Rheumatology (London, England)|July 6, 2023
Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysisAlisson Pugliesi, Amanda Borges de Oliveira, Ana Beatrice Oliveira, et al.
Pageof 9